CJC-1295 with DAC
Long-acting GHRH analog with drug affinity complex for extended half-life studies.
CJC-1295 with DAC is a modified growth-hormone-releasing hormone analog carrying a drug affinity complex, which substantially extends its half-life in research models. It is studied for sustained growth-hormone pulse patterns compared with short-acting GHRH analogs.
Ingredients
CJC-1295 DAC (≥98% purity by HPLC). 5 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per your study protocol. Store lyophilized at 2–8°C, protected from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Laboratory research use only. Not approved for human use. Not intended to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping on orders over $150
Specifications
Customer Reviews
Good value for the research being conducted. Fast shipping.
We have ordered several times and the quality has been consistent every time.
Reliable supplier, strong reconstitution characteristics, no residue.
Great for our continuing research protocols. COA matched expectations.
Related Products
Ipamorelin / CJC-1295 Blend
Synergistic growth-hormone secretagogue blend studied for vitality and recovery.
Ipamorelin
Selective pentapeptide growth-hormone secretagogue, supplied on its own.
CJC-1295 No DAC
Short-acting modified GHRH analog (mod GRF 1-29) for pulsatile-release research.
IGF-1 LR3
Long-arginine IGF-1 analog studied for cell growth and differentiation pathways.